Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study

<div>Cumulative rates of recurrent hyperthyroidism in Graves’ hyperthyroid patients who were randomly assigned to continue (CONT-MMI) (83 cases) represented in a dotted line and to discontinue low-dose methimazole therapy (DISCONT-MMI) (90 cases) represented in a solid line.</div>

International Journal of Endocrinology

fig2

Figure 2

Figure 2: Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study 

Figure 2 | Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study 